The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
Open accessAbstract
Background Intensive treatment of multiple cardiovascular risk factors can halve mortality among people with established type 2 diabetes. We investigated the effect of early multifactorial treatment after diagnosis by screening.Methods In a pragmatic, cluster-randomised, parallel-group trial done in Denmark, the Netherlands, and the UK, 343 general practices were randomly assigned screening of registered patients aged 40-69 years without known diabetes followed by routine care of diabetes or screening followed by intensive treatment of multiple risk factors. The primary endpoint was first cardiovascular event, including cardiovascular mortality and morbidity, revascularisation, and non-traumatic amputation within 5 years. Patients and staff assessing outcomes were unaware of the practice's study group assignment. Analysis was done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00237549.Findings Primary endpoint data were available for 3055 (99·9%) of 3057 screen-detected patients. The mean age was 60·3 (SD 6·9) years and the mean duration of follow-up was 5·3 (SD 1·6) years. Improvements in cardiovascular risk factors (HbA(1c) and cholesterol concentrations and blood pressure) were slightly but significantly better in the intensive treatment group. The incidence of first cardiovascular event was 7·2% (13·5 per 1000 person-years) in the intensive treatment group and 8·5% (15·9 per 1000 person-years) in the routine care group (hazard ratio 0·83, 95% CI 0·65-1·05), and of all-cause mortality 6·2% (11·6 per 1000 person-years) and 6·7% (12·5 per 1000 person-years; 0·91, 0·69-1·21), respectively.Interpretation An intervention to promote early intensive management of patients with type 2 diabetes was associated with a small, non-significant reduction in the incidence of cardiovascular events and death.Funding National Health Service Denmark, Danish Council for Strategic Research, Danish Research Foundation for General Practice, Danish Centre for Evaluation and Health Technology Assessment, Danish National Board of Health, Danish Medical Research Council, Aarhus University Research Foundation, Wellcome Trust, UK Medical Research Council, UK NIHR Health Technology Assessment Programme, UK National Health Service R&D, UK National Institute for Health Research, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Novo Nordisk, Astra, Pfizer, GlaxoSmithKline, Servier, HemoCue, Merck.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care) trial showed that microvascular or macrovascular events were not significantly reduced after 5 or 10 years (17% and 13% reduction, respectively), while intervention only slightly improved HbA1c.364,365”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [365]
In the citing paper
“These positive effects were not observed in the clinical intervention trials of intensified, multifactorial treatment for T2DM in primary care and early in the disease trajectory.”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [365]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Research works printed but not linked: 2
- Rutten, 1999, Dutch College of General Practitioners. Practice guideline diabetes mellitus type 2, Huisarts Wetensch, 42, 67
- Rutten, 2006, Dutch Guidelines on Type 2 Diabetes Mellitus. Dutch College of General Practitioners, Huisarts Wetensch, 49, 137
Cited by
Sorted by citations
Items 301–400 of 462
Dutt, C., Salles, J. E. N., Joshi, S., Nair, T., Chowdhury, S., Mithal, A., Mohan, V., Kasliwal, R. R., Sharma, S., Tijssen, J. G. P., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 7
Viljoen, A., Chubb, B., Malkin, S. J. P., Berry, S., Hunt, B., & Bain, S. C. (2022) · The European Journal of Health Economics · doi:10.1007/s10198-022-01514-1 · Cited by 7
Backholer, K., Chen, L., & Shaw, J. E. (2012) · Pathology · doi:10.1097/pat.0b013e32834e8e12 · Cited by 7
Atorvastatin associated with gamma glutamyl transpeptidase elevation in a hyperlipidemia patient
Xu, Y., & Wu, Y. (2020) · Medicine · doi:10.1097/md.0000000000022572 · Cited by 7
Cooper, A., Schliemann, D., Long, G. H., Griffin, S. J., Simmons, R. K., & on behalf of the ADDITION-Cambridge study team (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.79 · Cited by 7
Self-citationGlucose dysregulation phenotypes — time to improve outcomes
Zaccardi, F., & Khunti, K. K. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0092-3 · Cited by 7
Self-citationMayige, M. T. (2014) · Cited by 7
Lundström, H., Siersma, V., Nielsen, A. B. S., Brodersen, J., Reventlow, S. D., Andersen, P. K., & Olivarius, N. D. F. (2014) · Diabetologia · doi:10.1007/s00125-014-3204-1 · Cited by 6
Piniés, J. A., González-Carril, F., & Arteagoitia, J. M. (2015) · Avances en Diabetología · doi:10.1016/j.avdiab.2015.02.001 · Cited by 6
Effects of glucose-lowering agents on ischemic stroke
Avgerinos, K. I., & Τζιόμαλος, Κ. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.270 · Cited by 7
Nguyen, A., Khafagy, R. T. M., Hashemy, H., Kuo, K. H. M., Roshandel, D., Paterson, A. D., & Dash, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1146099 · Cited by 9
Quiñones, A. R., Richardson, J., Freeman, M., O'Neil, M. E., & Kansagara, D. L. (2012) · Europe PMC (PubMed Central) · Cited by 6
Xu, H., Luo, J., & Wu, B. (2015) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2015.01.005 · Cited by 6
External validation of two diabetes risk scores in a young UK South Asian population
Gray, L. J., Khunti, K., Wilmot, E. G., Yates, T. E., & Davies, M. J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.018 · Cited by 6
Self-citationWu, W., Ren, M., Cheng, H., Yan, L., Qi, Y., Yang, C. H., & Yan, L. (2014) · Endocrine · doi:10.1007/s12020-013-0158-x · Cited by 6
Screening for Diabetes after Stroke and Transient Ischemic Attack
Kernan, W. N. (2013) · Cerebrovascular Diseases · doi:10.1159/000355142 · Cited by 6
Maindal, H. T., Toft, U., Lauritzen, T., & Sandbaek, A. (2012) · European Journal of Public Health · doi:10.1093/eurpub/cks076 · Cited by 6
Self-citationEpidemiology and Public Health
Wild, S. H., & Price, J. F. (2022) · doi:10.1093/med/9780198870197.003.0246 · Cited by 6
Khan, F., Hussain, T., Chaudhry, T. Z., Payal, F., Shehryar, A., Rehman, A., Ramadhan, A., Hayat, M. T., Dabas, M. M., & Khan, M. (2024) · Cureus · doi:10.7759/cureus.74400 · Cited by 7
Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus
Kapoor, K., George, P., & Miller, M. J. (2016) · Cardiology · doi:10.1159/000446471 · Cited by 5
Simmons, R. K., Bruun, N. H., Witte, D. R., Borch‐Johnsen, K., Jørgensen, M. E., Sandbæk, A., & Lauritzen, T. (2017) · Diabetologia · doi:10.1007/s00125-017-4230-6 · Cited by 5
Self-citationDambha‐Miller, H., Hounkpatin, H. O., Stuart, B. L., & Farmer, A. A. (2021) · Practical Diabetes · doi:10.1002/pdi.2355 · Cited by 5
Williams, B. A., Brady, J. P., Voyce, S. J., Kumar, N., Paprocki, Y., & RAJPURA, J. R. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14686 · Cited by 5
Aldafas, R., Crabtree, T. S. J., Vinogradova, Y., Gordon, J. P., & IDRIS, I. R. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2166489 · Cited by 5
Zur Überschätzung des Nutzens von Prävention
Mühlhauser, I. (2014) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2013.11.006 · Cited by 5
The case for diabetes screening: ADDITION-Europe
Preiss, D., & Sattar, N. A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60819-2 · Cited by 5
Frontoni, S., Solini, A., Fioretto, P., Natali, A., Zuccalà, A., Cosentino, F., & Penno, G. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.004 · Cited by 5
Frequency of Monitoring Diabetes in Primary Care: What Do Well-Controlled Patients Prefer?
Wermeling, P. R., van den Donk, M., Gorter, K. J., Beulens, J. W. J., & Rutten, G. E. H. M. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.07.012 · Cited by 5
Self-citationChatzikyrkou, C., & Menne, J. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.100 · Cited by 4
Jensen, A. D., Andersen, S. T., Charles, M., Bjerg, L., Witte, D. R., Gram, B., Jørgensen, M. E., Sandbæk, A., & Dalsgaard, E. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.09.001 · Cited by 5
Self-citationRosén, A., Otten, J., Stomby, A., Vallin, S., Wennberg, P., & Brunström, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062172 · Cited by 6
The long-term benefits of lifestyle interventions for prevention of diabetes
Wareham, N. J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70074-9 · Cited by 5
Self-citationShahi, N., & Tobe, S. W. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.052 · Cited by 5
ADDITION-Europe and the case for diabetes screening
Yudkin, J. S., Montori, V. M., Lipska, K. J., & Gale, E. A. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60142-1 · Cited by 5
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes
Sasako, T., Ueki, K., Miyoshi, K., Miyake, K., Aoyama, T., Okazaki, Y., Ishizuka, N., Yamauchi, T., Noda, M., Kadowaki, T., et al. (2025) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2025.3819 · Cited by 5
Hermans, M. P., Bouénizabila, E., Amoussou-Guénou, D., Ahn, S. A., & Rousseau, M. F. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0226-z · Cited by 4
Alruthia, Y., Aburisheh, K. H., Ata, S., Salleeh, R. B., Alqudhibi, S. B., Alqudhibi, R. B., Alkraidis, Z., Alkhalaf, H. H., Almogirah, A. A., Mujammami, M., et al. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102057 · Cited by 3
Considerations in the design of randomized trials to screen for type 2 diabetes
Echouffo-Tcheugui, J. B., & Prorok, P. C. (2014) · Clinical Trials · doi:10.1177/1740774513517062 · Cited by 4
Pacilli, A., Lamacchia, O., Fontana, A., Copetti, M., Cignarelli, M., Trischitta, V., & Cosmo, S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124536 · Cited by 4
Dalsgaard, E., Sandbæk, A., Griffin, S. J., Rutten, G. E. H. M., Khunti, K. K., Davies, M. J., Irving, G. J., Vos, R. C., Webb, D. R., Wareham, N. J., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14342 · Cited by 4
Self-citationXhakaza, L., Abrahams-October, Z., Mohammednur, M. M., Pearce, B., Adeniyi, O. V., Johnson, R., & Benjeddou, M. (2020) · African Health Sciences · doi:10.4314/ahs.v20i3.41 · Cited by 7
Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease
Yagyu, H., & Shimano, H. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13859 · Cited by 4
Schulze, M. B., & Hu, F. B. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_66-1 · Cited by 5
Optimal search strategies for identifying moderators and predictors of treatment effects in PubMed
Tummers, M., van Hoorn, R., Levering, C., Booth, A., van der Wilt, G. J., & Kievit, W. (2018) · Health Information & Libraries Journal · doi:10.1111/hir.12230 · Cited by 5
ADDITION-Europe: the first decade and beyond
Sasako, T., Kadowaki, T., & Ueki, K. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30347-x · Cited by 4
Vos, R. C., den Ouden, H., Daamen, L. A., Bilo, H. J. G., Denig, P., & Rutten, G. E. H. M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000949 · Cited by 4
Self-citationDraft FDA guidance for assessing the safety of glucose lowering therapies: a missed opportunity?
Khunti, K. K., Davies, M. J., Marx, N., & Buse, J. B. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30302-8 · Cited by 4
Self-citationEliraqi, G. M., Vistisen, D., Lauritzen, T., Sandbæk, A., Jørgensen, M. E., & Færch, K. (2015) · Diabetic Medicine · doi:10.1111/dme.12764 · Cited by 4
Self-citationYu, P., Yuan, Q., Ling, H., Tao, L., Peng, Z., & Pu, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01617-8 · Cited by 3
Khalil, H., Namara, K. M., & Pan, Y. (2013) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-2-9 · Cited by 3
den Ouden, H., Berends, J., Stellato, R. K., Beulens, J. W. J., & Rutten, G. E. H. M. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2669 · Cited by 3
Self-citationU.S. Preventive Services Task Force Criteria for Diabetes Screening
Aroda, V. R., & Fonseca, V. A. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.05.001 · Cited by 4
Cardiovascular risk factors and incident albuminuria in screen‐detected type 2 diabetes
Webb, D. R., Zaccardi, F., Davies, M. J., Griffin, S. J., Wareham, N. J., Simmons, R. K., Rutten, G. E. H. M., Sandbæk, A., Lauritzen, T., Borch‐Johnsen, K., et al. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2877 · Cited by 4
Self-citationHusdal, R., Adolfsson, E. T., Leksell, J. K., Eliasson, B., Jansson, S. P. O., Jerdén, L., Stålhammar, J., Steen, L., Wallman, T., Svensson, A., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108352 · Cited by 3
Grotta, R. L., Pellegrini, V., Prattichizzo, F., Amata, O., Panella, L., Frizziero, A., Visconti, M., Averame, G., Brasesco, P. C., Calabrese, I., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041127 · Cited by 2
Laxy, M., Wilson, E., Boothby, C. E., & Griffin, S. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2016-015295 · Cited by 3
Self-citationShah, M. K., Kondal, D., Patel, S. A., Singh, K., Devarajan, R., Shivashankar, R., Ajay, V. S., Menon, V. U., Varthakavi, P. K., Viswanathan, V., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.14124 · Cited by 3
The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
Schianca, G. P. C., Sola, D., Rossi, L. C., Fra, G. P., & Bartoli, E. (2012) · ISRN Endocrinology · doi:10.5402/2012/601380 · Cited by 3
Genezing van diabetes mellitus type 2?
Huls, M., van Dijk, M., & Boesten, M. (2013) · Huisarts en Wetenschap · doi:10.1007/s12445-013-0040-3 · Cited by 3
Primary care: the custodian of diabetes care?
Farooqi, A. M. (2012) · Practical Diabetes · doi:10.1002/pdi.1708 · Cited by 3
Diabetes research in primary care: fiction, reality or essential?
Khunti, K. K., & Seidu, S. (2018) · Diabetic Medicine · doi:10.1111/dme.13638 · Cited by 3
Self-citationPolypharmacology in Clinical Applications: Metabolic Disease Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_5 · Cited by 3
Management of type 2 diabetes mellitus and prediction of cardiovascular complications
van Dieren, S., Health, C., Health, J. O. C., Economics, E. &. H., van der Schouw, Y. T., Beulens, J. W. J., & Peelen, L. M. (2013) · Utrecht University Repository (Utrecht University) · Cited by 3
Li, M.-C., Zhang, J., Li, H., Li, Y., Wang, C., Zhu, H., & Liu, Z. (2025) · Journal of the American Nutrition Association · doi:10.1080/27697061.2025.2540940 · Cited by 2
Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
Schwarz, P. E. H., & Timpel, P. (2016) · Bulletin of the Karaganda University “Biology medicine geography Series” · doi:10.31489/2016bmg4/72-98 · Cited by 2
Seidu, S., Almaqhawi, A., Abdool, M., Kunutsor, S. K., Davies, M. J., & Khunti, K. K. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14715 · Cited by 2
Self-citationGhetti, G., Pradelli, L., Papageorgiou, G., Karpouzos, G., & Arikan, Y. (2023) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s400522 · Cited by 2
Ren, H., Berry, S., Malkin, S. J. P., Hunt, B., & Bain, S. C. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070473 · Cited by 4
Evaluation of a Diabetes Screening Clinical Decision Support Tool
Tseng, E., Stein, A., Wang, N., Mathioudakis, N. N., Yeh, H.-C., & Maruthur, N. M. (2024) · AJPM Focus · doi:10.1016/j.focus.2024.100287 · Cited by 2
Rathmann, W., & Jacobs, E. M. G. (2020) · Der Diabetologe · doi:10.1007/s11428-019-00564-z · Cited by 2
Should we still screen for type 2 diabetes after ADDITION-Cambridge? A low-income world perspective
Choukem, S. P., & Mbanya, J. C. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.025 · Cited by 2
Screening for diabetes: hope and despair
Sawicki, P. T. (2012) · Diabetologia · doi:10.1007/s00125-012-2553-x · Cited by 2
Why We Should Screen for Type 2 Diabetes in High-Risk Patients
Kirkman, M. S. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.021 · Cited by 2
Weight control: key to managing ‘diabesity’
Haslam, D. B. (2013) · The British Journal of Diabetes · doi:10.1177/1474651412471689 · Cited by 2
Test Your Memory-test: een mogelijk alternatief voor de MMSE1
Koekkoek, P. S., Rutten, G. E. H. M., van den Berg, E., Kappelle, J. L. J., & Biessels, G. J. (2013) · Neuropraxis · doi:10.1007/s12474-013-0023-y · Cited by 2
Self-citationLauritzen, T., Borch‐Johnsen, K., Davies, M. J., Rutten, G. E. H. M., Sandbæk, A., & Simmons, R. K. (2013) · Cited by 2
Self-citationScreening for Diabetes and Prediabetes
Gray, L. J., Willis, A. M., Webb, D. R., Davies, M. J., & Khunti, K. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_12-1 · Cited by 2
Self-citationCharles, M., Bruun, N. H., Simmons, R. K., Dalsgaard, E., Witte, D. R., Jørgensen, M. E., Christensen, B., Maindal, H. T., Rubak, S., Sandbæk, A., et al. (2020) · BJGP Open · doi:10.3399/bjgpopen20x101012 · Cited by 2
Self-citationShi, L., Ye, X., Lü, M., Wu, E. Q., Sharma, H., Thomason, D., Zhang, M., Wang, Y., & Fonseca, V. A. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0122-2 · Cited by 2
Berkinbaev, S. F., Dzhunusbekov, G. A., Danyarova, L., Байматовна, Т. А., & Shyman, Z. Z. (2016) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.6.78.2016.81857 · Cited by 2
Review: Biomarkers and Role in the Prediction and Detection of Type 2 Diabetes and Its Complications
Osahon, I. S. (2017) · Biomarkers Journal · doi:10.21767/2472-1646.100033 · Cited by 2
Screening with urinary dipsticks for reducing morbidity and mortality
Krogsbøll, L. T., Jørgensen, K. J., & Gøtzsche, P. C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010007 · Cited by 2
Tidlig og intensiv behandling ved type 2-diabetes
Aasheim, E. T. (2011) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.11.1014 · Cited by 1
Funck, K. L., Borregaard, B., Egstrup, K., Fredslund, E. K., Hansen, T. W., Kallestrup, P., Olsen, M. H., Reventlow, S. D., Rossing, P. R., Sandbæk, A., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-106018 · Cited by 3
Self-citationDépistage du diabète de type 1 et de type 2
Ékoé, J.-M., Punthakee, Z., Ransom, T. P. P., Prebtani, A. P. H., & Goldenberg, R. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.032 · Cited by 1
Zin en onzin van scherp instellen glucosegehalte
Rutten, G. E. H. M. (2013) · TvPO · doi:10.1007/s12503-013-0010-z · Cited by 1
Self-citationDe Test Your Memory-test: een alternatief voor de MMSE
Koekkoek, P. S., Rutten, G. E. H. M., van den Berg, E., Kappelle, J. L. J., & Biessels, G. J. (2013) · Huisarts en Wetenschap · doi:10.1007/s12445-013-0320-y · Cited by 1
Self-citationThe effect of quality of care on cardiovascular risk factors in newly diagnosed diabetic patients.
Teimouri, A., Iraj, B., Amini, M., & Hovsepian, S. (2014) · Europe PMC (PubMed Central) · Cited by 1
Chatzikyrkou, C., Haller, H. G., & Menne, J. (2012) · Der Internist · doi:10.1007/s00108-011-2891-7 · Cited by 1
Zeyfang, A. (2017) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-017-1315-2 · Cited by 1
AssociationofanIntensiveLifestyleIntervention With Remission of Type 2 Diabetes
Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J. P., Pownall, H. J., Johnson, K., Safford, M. M., Kitabchi, A. E., et al. (2016) · Cited by 1
Principles of Diabetes Care and Lifestyle Modification
Moon, M. K. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_8 · Cited by 3
Kuneinen, S. M., Kautiainen, H., Ekblad, M. O., & Korhonen, P. E. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.08.004 · Cited by 1
Management of diabetes in the community
Farooqi, A. M. (2014) · Medicine · doi:10.1016/j.mpmed.2014.10.004 · Cited by 1
Jvs, K., Niveditha, G., Harsha, K., & Prasanna, K. M. (2013) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences · Cited by 1
Charles, M., Skriver, M. V., Griffin, S. J., Simmons, R. K., Witte, D. R., Dalsgaard, E., Lauritzen, T., & Sandbæk, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170697 · Cited by 1
Self-citationDiabetes Management in the United States
Ali, M. K., Shah, M. K., & Moin, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_17 · Cited by 1
Nutritional Management of Diabetes
Malik, U. R. (2020) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000220
Diabetes Management in the United States
Shah, M. K., Khan, F. N., & Ali, M. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_19 · Cited by 1
Causation in evidence‐based medicine: in reply to K erry et al.
Strand, A., & Parkkinen, V. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12304 · Cited by 1
Metadata
- Authors
- Griffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., & Lauritzen, T.
- Affiliations
- University of Cambridge (GB)
- University of Leicester (GB)
- University Medical Center Utrecht (NL)
- Aarhus University (DK)
- Wellcome/MRC Institute of Metabolic Science (GB)
- Corresponding author
- Griffin, Simon J
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 378
- Issue
- 9786
- Pages
- 156-167
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3136726
- OpenAlex
- W2146392529
- Cited by
- 462
- References
- 43
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 17 · 2023: 14 · 2022: 21 · 2021: 18 · 2020: 35 · 2019: 31 · 2018: 30 · 2017: 38 · 2016: 30 · 2015: 49 · 2014: 46 · 2013: 46 · 2012: 56
- FWCI
- 50.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Funders
- the Wellcome Trust (G061895)
- the Medical Research Council (G0001164)
- the NIHR Health Technology Assessment Programme (08/116/300)
- National Health Service R&D support funding (RP-PG-0606-1259)
- Department of Health and ad hoc Support Sciences, the NIHR Health Technology Assessment Programme (08/116/300)
- the Department of Health NIHR Programme Grant funding scheme (RP-PG-0606-1272)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, cardiovascular risk management, diabetes screening, cardiovascular events, cardiovascular mortality, all-cause mortality, revascularization, non-traumatic amputation, HbA1c, blood pressure, cholesterol, general practice, primary prevention, secondary prevention, risk stratification
- MeSH terms
- Aged, Denmark, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Mass Screening, Middle Aged, Netherlands, Risk Factors, Cluster Analysis, Outcome Assessment, Health Care, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
